I agree that this site is using cookies. You can find further informations here.
X
Ballas, Marc
56  results:
Search for persons X
?
1

INDUCE-2: A Phase I/II, open-label, two-part study of felad..:

Hilton, John F. ; Ott, Patrick A. ; Hansen, Aaron R....
Cancer Immunology, Immunotherapy.  73 (2024)  3 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
2

Model‐based meta‐analysis of non‐small cell lung cancer wit..:

Turner, David C. ; Wada, Russ ; Zhou, Helen...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  11 - p. 1751-1763 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Immuno-PET Monitoring of CD8+ T Cell Infiltration Post ICOS..:

Alsaid, Hasan ; Cheng, Shih-Hsun ; Bi, Meixia...
Molecular Imaging and Biology.  25 (2022)  3 - p. 528-540 , 2022
Link: https://doi.org/10.1007/..
 
?
4

A vision of immuno-oncology: the Siena think tank of the It..:

Maio, Michele ; Lahn, Michael ; Di Giacomo, Anna Maria...
Journal of Experimental & Clinical Cancer Research.  40 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
5

Phase I trials of the lysine-specific demethylase 1 inhibit..:

Roboz, Gail J. ; Yee, Karen ; Verma, Amit...
Leukemia & Lymphoma.  63 (2021)  2 - p. 463-467 , 2021
Link: https://doi.org/10.1080/..
 
?
6

Immunodynamics of explanted human tumors for immuno‐oncolog:

Dubuisson, Agathe ; Fahrner, Jean‐Eudes ; Goubet, Anne‐Gaëlle...
EMBO Molecular Medicine.  13 (2020)  1 - p. , 2020
Link: https://doi.org/10.15252..
 
?
7

PD-L1 expression in advanced NSCLC: Insights into risk stra..:

Brody, Robert ; Zhang, Yiduo ; Ballas, Marc...
Lung Cancer.  112 (2017)  - p. 200-215 , 2017
Link: https://doi.org/10.1016/..
 
?
8

A Phase III Study of Durvalumab (MEDI4736) With or Without ..:

Planchard, David ; Yokoi, Takashi ; McCleod, Michael J....
Clinical Lung Cancer.  17 (2016)  3 - p. 232-236.e1 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Prognostic significance of clinical factors and Akt activat..:

Tsurutani, Junji ; Steinberg, Seth M. ; Ballas, Marc...
Lung Cancer.  55 (2007)  1 - p. 115-121 , 2007
Link: https://doi.org/10.1016/..
 
?
10

Phase I, Open-Label, Dose-Escalation Study of the Safety, P..:

Bauer, Todd M. ; Besse, Benjamin ; Martinez-Marti, Alex...
Journal of Thoracic Oncology.  14 (2019)  10 - p. 1828-1838 , 2019
Link: https://doi.org/10.1016/..
 
?
11

A Pilot Study of Sirolimus in Subjects with Cowden Syndrome..:

Komiya, Takefumi ; Blumenthal, Gideon M. ; DeChowdhury, Roopa...
The Oncologist.  24 (2019)  12 - p. 1510-e1265 , 2019
Link: https://doi.org/10.1634/..
 
?
12

A Phase II, Open-Label Study of Ramucirumab in Combination ..:

Camidge, D. Ross ; Berge, Eamon M. ; Doebele, Robert C....
Journal of Thoracic Oncology.  9 (2014)  10 - p. 1532-1539 , 2014
Link: https://doi.org/10.1097/..
 
?
13

A phase I trial of the HIV protease inhibitor nelfinavir in..:

Blumenthal, Gideon M. ; Gills, Joell J. ; Ballas, Marc S....
Oncotarget.  5 (2014)  18 - p. 8161-8172 , 2014
Link: https://doi.org/10.18632..
 
?
14

Phase II trial of lapatinib in adult and pediatric patients..:

Karajannis, Matthias A. ; Legault, Geneviève ; Hagiwara, Mari...
Neuro-Oncology.  14 (2012)  9 - p. 1163-1170 , 2012
Link: https://doi.org/10.1093/..
 
?
15

PTEN hamartomatous tumor syndromes (PHTS): Rare syndromes w..:

LoPiccolo, Jaclyn ; Ballas, Marc S. ; Dennis, Phillip A.
Critical Reviews in Oncology/Hematology.  63 (2007)  3 - p. 203-214 , 2007
Link: https://doi.org/10.1016/..
 
1-15